Financial Fitness Check: Examining Sagimet Biosciences Inc (SGMT)’s Key Ratios

Kiel Thompson

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

In the latest session, Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $6.67 down -8.25% from its previous closing price of $7.27. In other words, the price has decreased by -$8.25 from its previous closing price. On the day, 1.51 million shares were traded. SGMT stock price reached its highest trading level at $7.01 during the session, while it also had its lowest trading level at $6.32.

Ratios:

For a deeper understanding of Sagimet Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.04 and its Current Ratio is at 13.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In the most recent recommendation for this company, Wedbush on August 11, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.

On July 24, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $28.Canaccord Genuity initiated its Buy rating on July 24, 2025, with a $28 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’25 when Kemble George sold 37,688 shares for $7.69 per share. The transaction valued at 289,979 led to the insider holds 81,005 shares of the business.

GEORGE KEMBLE bought 37,688 shares of SGMT for $295,851 on Nov 20 ’25. On Jul 21 ’25, another insider, Happel David, who serves as the President & CEO of the company, sold 65,478 shares for $9.13 each. As a result, the insider received 598,115 and left with 689,722 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 216919072 and an Enterprise Value of 100341064.

Stock Price History:

The Beta on a monthly basis for SGMT is 3.29, which has changed by 0.35294116 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is -11.53%, while the 200-Day Moving Average is calculated to be 9.66%.

Shares Statistics:

For the past three months, SGMT has traded an average of 522.00K shares per day and 553640 over the past ten days. A total of 31.00M shares are outstanding, with a floating share count of 26.29M. Insiders hold about 19.15% of the company’s shares, while institutions hold 32.70% stake in the company. Shares short for SGMT as of 1761868800 were 3127997 with a Short Ratio of 5.99, compared to 1759190400 on 2731112. Therefore, it implies a Short% of Shares Outstanding of 3127997 and a Short% of Float of 10.89.

Earnings Estimates

As of right now, 8.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.38 and low estimates of -$0.44.

Analysts are recommending an EPS of between -$1.64 and -$1.7 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.9, with 8.0 analysts recommending between -$1.65 and -$2.14.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.